These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


519 related items for PubMed ID: 10817105

  • 1. Bupropion sustained release versus paroxetine for the treatment of depression in the elderly.
    Weihs KL, Settle EC, Batey SR, Houser TL, Donahue RM, Ascher JA.
    J Clin Psychiatry; 2000 Mar; 61(3):196-202. PubMed ID: 10817105
    [Abstract] [Full Text] [Related]

  • 2. A multicenter evaluation of the efficacy and safety of 150 and 300 mg/d sustained-release bupropion tablets versus placebo in depressed outpatients.
    Reimherr FW, Cunningham LA, Batey SR, Johnston JA, Ascher JA.
    Clin Ther; 1998 Mar; 20(3):505-16. PubMed ID: 9663366
    [Abstract] [Full Text] [Related]

  • 3. Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies.
    Clayton AH, Croft HA, Horrigan JP, Wightman DS, Krishen A, Richard NE, Modell JG.
    J Clin Psychiatry; 2006 May; 67(5):736-46. PubMed ID: 16841623
    [Abstract] [Full Text] [Related]

  • 4. Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.
    Trivedi MH, Pigotti TA, Perera P, Dillingham KE, Carfagno ML, Pitts CD.
    J Clin Psychiatry; 2004 Oct; 65(10):1356-64. PubMed ID: 15491239
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline.
    Croft H, Settle E, Houser T, Batey SR, Donahue RM, Ascher JA.
    Clin Ther; 1999 Apr; 21(4):643-58. PubMed ID: 10363731
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Bupropion versus selective serotonin-reuptake inhibitors for treatment of depression.
    Nieuwstraten CE, Dolovich LR.
    Ann Pharmacother; 2001 Dec; 35(12):1608-13. PubMed ID: 11793630
    [Abstract] [Full Text] [Related]

  • 15. Venlafaxine extended-release: a review of its use in the management of major depression.
    Wellington K, Perry CM.
    CNS Drugs; 2001 Dec; 15(8):643-69. PubMed ID: 11524036
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and tolerability of controlled-release and immediate-release paroxetine in the treatment of depression.
    Golden RN, Nemeroff CB, McSorley P, Pitts CD, Dubé EM.
    J Clin Psychiatry; 2002 Jul; 63(7):577-84. PubMed ID: 12143913
    [Abstract] [Full Text] [Related]

  • 17. Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression.
    Fava M, Rosenbaum JF, Hoog SL, Tepner RG, Kopp JB, Nilsson ME.
    J Affect Disord; 2000 Aug; 59(2):119-26. PubMed ID: 10837880
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Paroxetine versus placebo: a double-blind comparison in depressed patients.
    Claghorn JL, Kiev A, Rickels K, Smith WT, Dunbar GC.
    J Clin Psychiatry; 1992 Dec; 53(12):434-8. PubMed ID: 1487471
    [Abstract] [Full Text] [Related]

  • 20. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    Lenox-Smith AJ, Jiang Q.
    Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 26.